| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
|
Ehmsen, Sidse
|
|
|
39 |
8 |
p. 1034-1036
|
artikel
|
| 2 |
Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
|
Greenberger, Lee M.
|
|
|
39 |
8 |
p. 1031-1033
|
artikel
|
| 3 |
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
|
Pearson, Joel D.
|
|
|
39 |
8 |
p. 1115-1134.e12
|
artikel
|
| 4 |
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
|
Hanker, Ariella B.
|
|
|
39 |
8 |
p. 1099-1114.e8
|
artikel
|
| 5 |
Developing and validating model systems for immuno-oncology
|
McCarthy, Claire E.
|
|
|
39 |
8 |
p. 1018-1022
|
artikel
|
| 6 |
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
|
Marin-Bejar, Oskar
|
|
|
39 |
8 |
p. 1135-1149.e8
|
artikel
|
| 7 |
From bench to bedside: Single-cell analysis for cancer immunotherapy
|
Davis-Marcisak, Emily F.
|
|
|
39 |
8 |
p. 1062-1080
|
artikel
|
| 8 |
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
|
Van Oekelen, Oliver
|
|
|
39 |
8 |
p. 1028-1030
|
artikel
|
| 9 |
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
|
Griffiths, Elizabeth A.
|
|
|
39 |
8 |
p. 1045-1047
|
artikel
|
| 10 |
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
|
Hill, Joshua A.
|
|
|
39 |
8 |
p. 1037-1038
|
artikel
|
| 11 |
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
|
Addeo, Alfredo
|
|
|
39 |
8 |
p. 1091-1098.e2
|
artikel
|
| 12 |
Interleukin-1 in tumor progression, therapy, and prevention
|
Garlanda, Cecilia
|
|
|
39 |
8 |
p. 1023-1027
|
artikel
|
| 13 |
Is resistance to targeted therapy in cancer inevitable?
|
Smith, Lorey K.
|
|
|
39 |
8 |
p. 1047-1049
|
artikel
|
| 14 |
Lineage tracing reveals metastatic dynamics
|
Lee, Eunmi
|
|
|
39 |
8 |
p. 1050-1052
|
artikel
|
| 15 |
Multiplex computational pathology for treatment response prediction
|
Lu, Ming Y.
|
|
|
39 |
8 |
p. 1053-1055
|
artikel
|
| 16 |
Optic nerve activity promotes the growth of optic pathway gliomas: Shedding light on the glioma microenvironment
|
da Silva, Bárbara
|
|
|
39 |
8 |
p. 1056-1058
|
artikel
|
| 17 |
Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic
|
Labaki, Chris
|
|
|
39 |
8 |
p. 1042-1044
|
artikel
|
| 18 |
Seroconversion rates following COVID-19 vaccination among patients with cancer
|
Thakkar, Astha
|
|
|
39 |
8 |
p. 1081-1090.e2
|
artikel
|
| 19 |
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
|
Simeonov, Kamen P.
|
|
|
39 |
8 |
p. 1150-1162.e9
|
artikel
|
| 20 |
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic
|
Bayle, Arnaud
|
|
|
39 |
8 |
p. 1039-1041
|
artikel
|
| 21 |
The promise and peril of KRAS G12C inhibitors
|
Moore, Amanda R.
|
|
|
39 |
8 |
p. 1059-1061
|
artikel
|
| 22 |
Tumor heterogeneity
|
Pe’er, Dana
|
|
|
39 |
8 |
p. 1015-1017
|
artikel
|
| 23 |
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
|
Geuijen, Cecile A.W.
|
|
|
39 |
8 |
p. 1163-1164
|
artikel
|
Tijdschrift beschrijving